How vulnerable is Denmark to pharmaceutical downturn?
Denmark’s exceptional growth in recent years has been driven by one sector (pharmaceuticals) and one firm within that sector (Novo Nordisk). Its output has declined this year, raising questions about how much it will support growth in future. But even if Novo Nordisk falls short of expectations, the Danish economy is likely to be resilient.
Subscriber content
Read this in full, free
Start a free trial and use one of your 10 free starter credits to unlock this piece.
